Alternatives to Adimab
Adimab is a Biotech tool: adimab is a biotechnology company that discovers and develops therapeutic antibodies using its proprietary yeast-based platform. Here are the 60 closest alternatives, compared on pricing, features and what real users say.
The 20 closest Biotech companies to Adimab
- Website
32 Biosciences42BiotechSan Diego, United States$12.0MDevelops novel therapeutic antibodies for oncology and autoimmune diseases.
- Website
AbCellera41BiotechVancouver, Canada$10.0MAI-powered platform for antibody discovery and development to create new medicines.
- Website
Alvox Bio31Life SciencesCambridge, United StatesAlvox Bio is a life sciences startup developing novel therapeutic antibodies.
- Website
Hogen Biotech30Life SciencesSan Diego, United StatesHogen Biotech is a life sciences startup focused on developing novel therapeutic antibodies.
- Website
Khosen Bio35Biotechירושלים, IsraelDeveloping novel therapeutic antibodies for challenging diseases.
- Website
Antiverse52BiotechnologyLondon, United Kingdom$15.7MAI-powered antibody discovery platform.
- Website
Adaptive Biotechnologies69BiotechSeattle, United States$300.0MLeveraging the adaptive immune system to diagnose and treat disease.
- Website CSCSF Biosciences48BiotechCambridge, United States$15.0M
Develops novel protein engineering and directed evolution technologies for therapeutic discovery.
- Website
LifeMine Therapeutics Inc.60BiotechnologyWatertown, United States$543.0MClinical-stage biopharmaceutical company leveraging a proprietary platform to discover and develop novel precision medicines from fungi.
- Website
Nona Biosciences62BiotechShanghai, ChinaBiotechnology company specializing in antibody discovery and development with integrated 'Idea to IND' solutions.
- Website
Mabylon35BiotechGeneva, Switzerland$35.8MMabylon is a biotechnology company focused on developing innovative antibody-based therapies for infectious diseases and cancer.
- Website
Denali Therapeutics70BiotechSouth San Francisco, United States$1.0BBiopharmaceutical company developing therapies for neurodegenerative diseases, focusing on crossing the blood-brain barrier.
- Website
Cradle69BiotechAmsterdam, Netherlands$102.4MCradle Bio B.V. is a Dutch, Swiss biotechnology company that develops software using machine learning for protein engineering. It was founded in 2021 and is base
- Website
BeiGene64BiotechCambridge, United States$358.0MA global oncology company developing and commercializing innovative cancer treatments.
- Website
Manifold Bio63BiotechBoston, United States$118.0MAI-guided drug discovery platform for tissue-targeted medicines.
- Website
BioSymetrics63BiotechBoston, United States$6.6MPhenomics-driven AI company translating disease biology into precision medicine discoveries.
- Website LELexeo Therapeutics61BiotechNew York City, United States$495.0M
Clinical-stage genetic medicine company developing AAV-mediated treatments for cardiovascular and Alzheimer's diseases.
- Website
Moleculent61BiotechStockholm, Sweden$46.0MMapping cell-cell communication at scale in human tissue.
- Website
Paratus Sciences46BiotechNew York, United StatesBiotech startup leveraging bat biology for novel therapeutics in immunology and cardiometabolic diseases.
- Website
Deep Genomics61BiotechToronto, Canada$241.0MAI-powered biotechnology company developing RNA therapeutics for genetic diseases.
Showing the 20 closest matches. See the rest on the Adimab profile.
Compare Adimab head to head
Side by side on what each one does, what it costs, and what real users report.